Maka Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Isi ụlọ ọrụ251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Tọrọ ntọala2018
ỌnọdụNa-arụ ọrụ

Patent1 patent

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Chọọ patent niile na Heelky →

Nyocha

Enweghị nyocha ugbu a. Ị rụrụ ọrụ na Assertio Therapeutics, Inc.? Bụrụ onye mbụ kekọrịta ahụmahụ gị.

Dee nyocha →

Kọntaktị & njikọ

Ebe

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Nke a ọ bụ ụlọ ọrụ gị?

Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.

Kwuo ibe a

Kekọrịta ụlọ ọrụ a

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Detuo njikọ

Kekọrịta na

Koodu QR

Jiri igwefoto ekwentị skenịa ya iji mepee ibe a, ma ọ bụ budata ya maka akwụkwọ mgbasa ozi, slaịdị ma ọ bụ baajị.

Sonye na Heelky iji jikọọ, were ndị ọrụ ma too

Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.

Sonye ugbu a — ọ bụ n'efu

Họrọ asụsụ gị

Heelky ga-echeta nhọrọ gị.

Asụsụ ndị ọzọ

Asụsụ dị: 70 Maka asụsụ na Heelky